Viewing Study NCT01858168


Ignite Creation Date: 2025-12-24 @ 5:52 PM
Ignite Modification Date: 2025-12-28 @ 1:28 AM
Study NCT ID: NCT01858168
Status: COMPLETED
Last Update Posted: 2025-12-19
First Post: 2013-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module